Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.

See All PCSK9 Related Kits

Specification Related Products

Cat.No. :	Kit-1806
Product Overview :	PCSK9 is a crucial player in the regulation of plasma cholesterol homeostasis. It binds to the ectodomain of hepatic low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation. PCSK9 acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. The D374T mutation results in higher affinity of PCSK9 for LDLR.
Size :	384 reactions
Applications :	Great for screening small molecular inhibitors for drug discovery and HTS applications.
Storage :	At least 6 months from date of receipt when stored as directed.